`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`Biocon Pharma Limited
`Petitioner,
`
`v.
`
`Novartis Pharmaceutical Corporation,
`Patent Owner.
`
`_____________________
`
`Case IPR2020-01263
`Patent No. 8,101,659
`
`
`
`PETITIONER’S REQUEST FOR REFUND OF IPR FEES
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2020-01263
`Patent No. 8,101,659
`
`
`Petitioner Biocon Pharma Limited et al. (“Biocon”) requests a refund in the
`
`
`
`amount of $ 15,000 to be paid to Deposit Acct. No. 501290 (Customer ID No.
`
`27160) pursuant to the U.S. Patent and Trademark Office’s Final Rule Setting and
`
`Adjusting Patent Fees, 78 F.R. 4211, 4234-35 (Jan. 18, 2013).
`
`On August 7, 2020, Biocon filed a Petition for inter partes review against
`
`U.S. Patent No. 8,101,659, proceeding IPR2020-01263. In accordance with the fee
`
`schedule specified in 37 C.F.R. § 42.15(a), Biocon deposited an electronic payment
`
`in the amount of $ 30,500 with the PTO at the time of filing its Petition. Biocon’s
`
`payment consisted of $ 15,500 in fees associated with Biocon’s inter partes review
`
`request, and a further $ 15,000 in Post-Institution fees.
`
`On February 16, 2021, the Board entered a decision to terminate proceeding
`
`IPR2020-01263 denying institution. Paper 12. Accordingly, Biocon requests a
`
`refund in the amount of $15,000 for the Post-Institution fees.
`
`2
`
`
`
`
`
`
`
`Case IPR2020-01263
`Patent No. 8,101,659
`
`RESPECTFULLY SUBMITTED,
`
`
`/christopher b. ferenc/
`
`Christopher B. Ferenc
`Reg. No. 593656
`Katten Muchin Rosenman LLP
`2900 K Street NW
`Washington, DC 20007
`
`Lead Counsel for Petitioner
`Biocon Pharma Limited et al.
`
`
`
`
`
`
`
`
`Date: June 8, 2021
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`
`
`
`
`
`CERTIFICATION OF SERVICE
`
`Case IPR2020-01263
`Patent No. 8,101,659
`
`
`The undersigned certifies a copy of the foregoing PETITIONER’S
`
`REQUEST FOR REFUND OF IPR FEES was served on June 8, 2021 via
`
`electronic mail directed to the counsel of record for the Patent Owner at the
`
`following:
`
`
`
`Nicholas N. Kallas
`Christina Schwarz
`Shannon Clark
`Laura K. Fishwick
`VENABLE LLP
`1290 Avenue of the Americas
`New York, New York 10104
`(212) 218-2100
`nkallas@venable.com
`cschwarz@venable.com
`skclark@venable.com
`lfishwick@venable.com
`
`
`
`
`
`/christopher b. ferenc/
`
`
`
` RESPECTFULLY SUBMITTED,
`
`
`
`
`Christopher B. Ferenc
`Reg. No. 593656
`Katten Muchin Rosenman LLP
`2900 K Street NW
`Washington, DC 20007
`
`Lead Counsel for Petitioner
`Biocon Pharma Limited et al.
`
`
`
`4
`
`